Rolland, R.; Loubet, A.; Bommart, S.; Monnin-Bares, V.; Zarqane, H.; Vanoverschelde, J.; Herman, F.; Molinari, N.; Kovacsik, H.
Safety, Efficacy and Mid-Term Outcome for Transarterial Embolization (TAE) of Renal Angiomyolipoma (AML) Using Ethylene Vinyl Alcohol Copolymer Liquid Embolic Agent (EVOH). J. Clin. Med. 2023, 12, 3385.
https://doi.org/10.3390/jcm12103385
AMA Style
Rolland R, Loubet A, Bommart S, Monnin-Bares V, Zarqane H, Vanoverschelde J, Herman F, Molinari N, Kovacsik H.
Safety, Efficacy and Mid-Term Outcome for Transarterial Embolization (TAE) of Renal Angiomyolipoma (AML) Using Ethylene Vinyl Alcohol Copolymer Liquid Embolic Agent (EVOH). Journal of Clinical Medicine. 2023; 12(10):3385.
https://doi.org/10.3390/jcm12103385
Chicago/Turabian Style
Rolland, Rémi, Antoine Loubet, Sébastien Bommart, Valérie Monnin-Bares, Hamid Zarqane, Juliette Vanoverschelde, Fanchon Herman, Nicolas Molinari, and Hélène Kovacsik.
2023. "Safety, Efficacy and Mid-Term Outcome for Transarterial Embolization (TAE) of Renal Angiomyolipoma (AML) Using Ethylene Vinyl Alcohol Copolymer Liquid Embolic Agent (EVOH)" Journal of Clinical Medicine 12, no. 10: 3385.
https://doi.org/10.3390/jcm12103385
APA Style
Rolland, R., Loubet, A., Bommart, S., Monnin-Bares, V., Zarqane, H., Vanoverschelde, J., Herman, F., Molinari, N., & Kovacsik, H.
(2023). Safety, Efficacy and Mid-Term Outcome for Transarterial Embolization (TAE) of Renal Angiomyolipoma (AML) Using Ethylene Vinyl Alcohol Copolymer Liquid Embolic Agent (EVOH). Journal of Clinical Medicine, 12(10), 3385.
https://doi.org/10.3390/jcm12103385